Home › NDC Lookup › RxCUI directory › RxCUI 597957

Dinoprostone 10 MG Vaginal Insert — RxCUI 597957

RxNorm drug concept · Semantic clinical drug
RxCUI 597957 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI597957
Official nameDinoprostone 10 MG Vaginal Insert
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asPGE2 10 MG Vaginal Insert
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dinoprostone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dinoprostone is a medication that mimics a natural hormone your body makes during late pregnancy to help prepare your cervix for labor. Your cervix needs to soften, thin out, and b...
  • What exactly is dinoprostone, and why do I need it?
  • Yes, you'll be awake throughout. Dinoprostone is placed in your vagina or cervix by your care team, and you'll be monitored closely the whole time. Some women feel mild cramping or...
  • Will I be awake and aware during the process? What will it feel like?
📖 Read our full Dinoprostone guide →

🕸️ Concept Web — How Dinoprostone 10 MG Vaginal Insert Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dinoprostone 10 MG Vaginal Insert RxCUI 597957

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dinoprostone 3478
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cervidil 215960
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dinoprostone Vaginal Insert 2109134
    • Dinoprostone Vaginal Product 1152203
    • Dinoprostone Vaginal Insert [Cervidil] 2697770
    • Cervidil Vaginal Product 2697769
    • Vaginal Insert 2107950
    • Vaginal Product 1151125
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dinoprostone 10 MG SCDC · 597956
  • Dinoprostone Vaginal Insert SCDF · 2109134
  • Dinoprostone Vaginal Product SCDG · 1152203

Brand-Name Concepts

  • Dinoprostone 10 MG Vaginal Insert [Cervidil] SBD · 597959
  • Dinoprostone 10 MG [Cervidil] SBDC · 597958
  • Dinoprostone Vaginal Insert [Cervidil] SBDF · 2697770
  • Cervidil Vaginal Product SBDG · 2697769
  • Cervidil BN · 215960

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 597957 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55566-2800-01 1 POUCH in 1 CARTON (55566-2800-1) / 10 mg in 1 POUCH (5556... CERVIDIL Ferring Pharmaceuticals Inc. 1995-03-30
Observed labelers: Ferring Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.